Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

Adagio Medical shares are trading higher by 215% during Thursday's session. The FDA granted Breakthrough Device Designation for the vCLAS cryoablation system. Learn the top momentum trading ...

LAGUNA HILLS, Calif., April 17, 2025--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ...

Short interest is currently not available. Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to ...